Los Angeles, CA4 Active Studies

Thrombocytopenia Clinical Trials in Los Angeles, CA

Find 4 actively recruiting thrombocytopenia clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
332
Enrolling

Recruiting Thrombocytopenia Studies in Los Angeles

About Thrombocytopenia Clinical Trials in Los Angeles

Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.

There are currently 4 thrombocytopenia clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 332 participants. Research is being sponsored by Takeda, argenx, Eli Lilly and Company and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Thrombocytopenia Clinical Trials in Los Angeles — FAQ

Are there thrombocytopenia clinical trials in Los Angeles?

Yes, there are 4 thrombocytopenia clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What thrombocytopenia treatments are being tested?

The 4 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.

Data updated March 2, 2026 from ClinicalTrials.gov